Skip to main content
. 2011 Mar 1;6(3):307–316. doi: 10.4161/epi.6.3.14182

Table 3.

Nuclear immunoreactivity of DNMT3b in ESCC patients (n = 44)

DNMT3b (%) p value
+ ++ +++ ++++
ESCC 27.3 18.2 15.9 27.3 11.4 p < 0.001
NT 56.8 36.4 4.5 2.3 0.0

NT, non-tumor tissue. The proportions of positive cells were evaluated using the scoring system to determine as negative (−) to extremely strong positive (++++) staining.